نتایج جستجو برای: a172

تعداد نتایج: 256  

2015
Gloria Perazzoli Jose Prados Raul Ortiz Octavio Caba Laura Cabeza Maria Berdasco Beatriz Gónzalez Consolación Melguizo Marta M. Alonso

BACKGROUND The use of temozolomide (TMZ) has improved the prognosis for glioblastoma multiforme patients. However, TMZ resistance may be one of the main reasons why treatment fails. Although this resistance has frequently been linked to the expression of O6-methylguanine-DNA methyltransferase (MGMT) it seems that this enzyme is not the only molecular mechanism that may account for the appearanc...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2004
Zhuo Zhang Hui Wang Gautam Prasad Mao Li Dong Yu James A Bonner Sudhir Agrawal Ruiwen Zhang

PURPOSE The MDM2 oncogene, amplified or overexpressed in many human cancers, has been suggested to be a novel target for cancer therapy. We have demonstrated a second-generation antisense antihuman-MDM2 oligonucleotide to have antitumor activity when administered alone or in combination with cancer chemotherapeutic agents. In the present study, we investigated the effect of the antisense oligon...

Journal: :Blood 1991
N B Lerner K H Nocka S R Cole F H Qiu A Strife L K Ashman P Besmer

The c-kit proto-oncogene encodes a 145- to 160-Kd transmembrane tyrosine kinase, which is a member of the platelet-derived growth factor receptor family and is allelic with the murine white spotting locus (W). W mutations affect several aspects of hematopoiesis, most notably erythroid progenitors and mast cells. A monoclonal antibody, YB5.B8, had been raised against the leukemic blasts of a pat...

Journal: :The Journal of pharmacology and experimental therapeutics 2004
Nicol Strakova Jiri Ehrmann Petr Dzubak Jan Bouchal Zdenek Kolar

Glioblastoma multiforme is the most common malignant brain tumor in adults, and it is among the most lethal of all cancers. Recent studies have shown that ligand activation of peroxisome proliferator-activated receptor (PPAR)-gamma can induce differentiation and inhibit proliferation of several cancer cells. In this study, we have investigated whether one PPARgamma ligand in particular, ciglita...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2009
Agnes Elias Markus D Siegelin Albert Steinmüller Andreas von Deimling Ulrike Lass Bernhard Korn Wolf Mueller

PURPOSE To identify and characterize epigenetically regulated genes able to predict sensitivity or resistance to currently tested chemotherapeutic agents in glioma therapy. EXPERIMENTAL DESIGN We used methylation-sensitive BeadArray technology to identify novel epigenetically regulated genes associated with apoptosis and with potential therapeutic targets in glioma therapy. To elucidate the f...

Journal: :Oncology reports 2007
Herwig M Strik Katharina Schmidt Paul Lingor Lars Tönges Wilfried Kugler Mirko Nitsche Gabriel A Rabinovich Mathias Bähr

Galectins are evolutionarily conserved beta-galactoside-binding lectins which recognize specific glycoconjugates on the cell surface and the extracellular matrix. Accumulating evidence indicates that these proteins are involved in a variety of physiological and pathological processes including tumor growth and metastasis. Up-regulated expression of galectin-1 is a hallmark of a variety of malig...

Journal: :iranian red crescent medical journal 0
mohsen rashidi department of pharmacology, school of medicine, shahid beheshti university of medical sciences, tehran, ir iran seyed ali ziai department of pharmacology, school of medicine, shahid beheshti university of medical sciences, tehran, ir iran taraneh moini zanjani department of pharmacology, school of medicine, shahid beheshti university of medical sciences, tehran, ir iran; department of pharmacology, school of medicine, shahid beheshti university of medical sciences, tehran, ir iran ahad khalilnezhad department of immunology, school of medicine, shahid beheshti university of medical sciences, tehran, ir iran hamidreza jamshidi department of pharmacology, school of medicine, shahid beheshti university of medical sciences, tehran, ir iran davar amani department of immunology, school of medicine, shahid beheshti university of medical sciences, tehran, ir iran

conclusions our findings indicate that umbelliprenin exhibits concentration-dependent inhibitory effects on various cell types; it is potentially toxic against the ht29, ct26, mcf-7, 4t1, a172, and gl26 cell lines, potentially harmful against bmdscs, and non-toxic against pbmcs. therefore, if our results are approved in the future, umbelliprenin can be an appropriate candidate for developing tr...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید